Form 4 for RGNX REGENXBIO Inc.
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001700659-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-03-12 | 2026-03-10 | RGNX | PAKOLA STEVE | Chief Medical Off | S - Sale | $10.35 | -5,124 | 247.9K | -2% | -$53.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | S | D | 5,124 | $10.35 | 247,926 | D | — | — |